I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cardiovascular and Renal Outcomes With Canagliflozin Accord..:
Neuen, Brendon L
;
Ohkuma, Toshiaki
;
Neal, Bruce
...
https://research.rug.nl/en/publications/491b8929-f047-4a62-9daf-211568e73532. , 2018
Link:
https://hdl.handle.net/11370/491b8929-f047-4a62-9daf-2..
RT Journal T1
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function:Data From the CANVAS Program
UL https://suche.suub.uni-bremen.de/peid=base-ftunigroningenpu:oai:pure.rug.nl:publications_491b8929-f047-4a62-9daf-211568e73532&Exemplar=1&LAN=DE A1 Neuen, Brendon L A1 Ohkuma, Toshiaki A1 Neal, Bruce A1 Matthews, David R A1 de Zeeuw, Dick A1 Mahaffey, Kenneth W A1 Fulcher, Greg A1 Desai, Mehul A1 Li, Qiang A1 Deng, Hsiaowei A1 Rosenthal, Norm A1 Jardine, Meg J A1 Bakris, George A1 Perkovic, Vlado YR 2018 K1 canagliflozin K1 cardiovascular diseases K1 diabetes mellitus K1 type 2 K1 glomerular filtration rate K1 kidney K1 renal insufficiency K1 chronic K1 sodium glucose cotransporter 2 K1 treatment outcome K1 COTRANSPORTER 2 INHIBITORS K1 TYPE-2 DIABETES-MELLITUS K1 SGLT2 INHIBITORS K1 RISK-FACTORS K1 DISEASE K1 EMPAGLIFLOZIN K1 DAPAGLIFLOZIN K1 HYPOTHESIS K1 PROTECTION K1 TRIAL JF https://research.rug.nl/en/publications/491b8929-f047-4a62-9daf-211568e73532 LK http://dx.doi.org/https://hdl.handle.net/11370/491b8929-f047-4a62-9daf-211568e73532 DO https://hdl.handle.net/11370/491b8929-f047-4a62-9daf-211568e73532 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)